Results 181 to 190 of about 2,022,996 (246)

Harnessing Tumor-Specific Transcript Diversity Uncovers a Shared Neoantigen Reservoir for Pancreatic Ductal Adenocarcinoma. [PDF]

MedComm (2020)
Zhao J, Li Q, Lin P, Yang Y, Yu H, Wen Y, Yu W, He H, Tao S, Zhang F, Li Y, Hu Z, Xie J, Chen Z, Huang S.   +14 more
europepmc   +1 more source

Tumor antigens across cancer progression: from immune recognition and selection to precision cancer immunotherapy. [PDF]

Front Immunol
Leong SP.
europepmc   +1 more source

Neoantigen nanovaccines for cancer immunotherapy: design strategies, translational bottlenecks, and clinical prospects. [PDF]

J Nanobiotechnology
Sun M, Xiao L, Yu Y.
europepmc   +1 more source

Mechanistic biomarkers for cancer vaccine development: from cancer cell biology to neoantigen-guided precision immunotherapy. [PDF]

Front Cell Dev Biol
Rusciano D.
europepmc   +1 more source

The Central Role of HLA Class II-Restricted Helper Neoantigen Vaccines in Cancer Immunotherapy. [PDF]

Cancers (Basel)
Morisaki T, Morisaki T.
europepmc   +1 more source

Therapeutic melanoma vaccines: Platforms, neoantigen strategies, and emerging combination immunotherapies. [PDF]

Ther Adv Vaccines Immunother
Mhanna D, Salman B, El Hakim R, Aridi L, Abou Ali W, Al Halabi B, Faour V, Harb F, Azar S, Ghadieh HE.   +9 more
europepmc   +1 more source

Advances and Challenges in mRNA Cancer Vaccines: Individualized Design and Delivery. [PDF]

Bioengineering (Basel)
Huang L, Tang Y, Chen X, Wu Z, Xiao J, Xiang Q, Tian H.   +6 more
europepmc   +1 more source

Predictors of Immune Checkpoint Blockade Response in dMMR Colorectal Cancer Using an Integrated Immune-Enhanced Multiomics Platform. [PDF]

Clin Cancer Res
Sinicrope FA, Sharma N, Mohiuddin M, Saberzadeh-Ardestani B, Graham RP, Lewis JT, Li B, Abbott CW, Boyle SM.   +8 more
europepmc   +1 more source

Prognostic value and immune landscape implications of using a novel homologous recombination repair pathway signature in prostate cancer: A retrospective cohort study. [PDF]

J Int Med Res
Wang F, Tian YE, Liu Q, Sha MO, Wang P, Huang X, Tuoheti K, Chen J, Cui QI.   +8 more
europepmc   +1 more source

Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction. [PDF]

Front Genet
Brlek P, Kolić J, Bulić L, Škaro V, Primorac D.   +4 more
europepmc   +1 more source